Modern Technologies in the Examination of Patients with Optic Nerve Atrophy Due to Multiple Sclerosis
https://doi.org/10.18008/1816-5095-2018-2S-246-253
Abstract
Purpose: to develop an algorithm for testing patients with optic nerve atrophy due to MS using microperimetry with the different functional disorders.
Patients and Methods. There were 20 patients (40 eyes) with the correct diagnosis of MS at the age of 33 ± 1.88 years in the study. The BCVA was from 0.1 to 1.0. Microperimetry was done on MP-1 (Nidek technologies, Vigonza, Italy) with the definition of mean sensitivity, stability and type of fixation. We chose the parameters of microperimetry: the research program, the size of the stimulus, the fixation mark and the test mode.
Results. The best program for diagnosing central visual field defects was the program macula 12° 10 dB, for paracentral visual field defects – retina 40° 20 dB. The testing was conducted by using a standard stimulus Goldmann III, mark and survey mode is selected individually, according at the various types of functional disorders. The visual acuity was from 0.1 to 0.4 in 11 eyes with optic nerve atrophy. There were revealed absolute or relative defects of the central field of vision and the decreasing of mean sensitivity to 8.21 ± 2.3 dB, unstable central fixation — 71.18 ± 10, 3%. In 29 eyes with optic nerve atrophy and visual acuity 0.5–1.0 have been identified relative small central visual field defects and paracentral visual field defects in the inferior side with a decrease in sensitivity to 15,32 ± 0,84 dB in the area of 6° from the fixing point, stable central fixation 88,96 ± 2,9%.
Conclusion. The authors developed an algorithm for testing patients with optic nerve atrophy due to MS. Using the algorithm identified the central and paracentral visual field defects with the decrease in the mean sensitivity.
About the Authors
E. E. IoylevaRussian Federation
MD, PhD, professor,
Beskudnikovsky blvd, 59a, Moscow, 127486
M. S. Krivosheeva
Russian Federation
ophthalmologist,
Beskudnikovsky blvd, 59a, Moscow, 127486
E. Yu. Markova
Russian Federation
MD, phD, professor,
Beskudnikovsky blvd, 59a, Moscow, 127486
References
1. Гусев Е.И., Завалишин И.А., Бойко А.Н. Рассеянный склероз, клиническое руководство. Москва; 2011:782. [Gusev E.I., Zavalishin I.A., Boiko A.N., Multiple sclerosis, clinical guidelines. Moscow; 2011:782. (In Russ.)]
2. Toosy A.T., Mason D.F., Miller D.H. Optic neuritis. Lancet Neurology. 2014;13:83– 99. DOI: 10.1016/S1474-4422(13)70259-x
3. Villoslada P., Cuneo A., Gelfand J., Hauser S.L., Green A. Color vision is strongly associated with retinal thinning in multiple sclerosis. Journal Multiple Sclerosis. 2012;18:991–9. DOI: 10.1177/1352458511431972
4. Gabilondo I., Martinez-Lapsia E.N., Martinez-Heras E., Frada-Pumar E., Llufriu S., Ortiz S., Bulich S., Sepulveda M., Falcon C., Berenguer J., Saiz A., Sanchez-Dalmau B., Villoslada P. Trans-synaptic axonal degeneration in the visual pathway in multiple sclerosis. Journal of Opthalmology. 2014;23:667–85. DOI: 10.1002/ana.24030
5. Fu Y. New imaging techniques in the diagnosis of multiple sclerosis. Expert Opinion Medical Diagnosis. 2008;2(9):1055–65. DOI: 10.1517/17530050802361161
6. Garcia-Martin E., Rodriguez-Mena D., Herrero R., Almarcegui C., Dolz I., Martin J. Neuro-ophthalmologic evaluation, quality of life, and functional disability in patients with MS. Neurology.2013;81:76–83. DOI: 10.1212/WNL.0b013e318299ccd9
7. Balcer L.J., Miller D.H., Reingold S.C., Cohen J. A Vision and vision-related outcome measures in multiple sclerosis. Brain.2015;138(1):11–27. DOI: 10.1093/ brain/awu335
8. Keltner J.L., Johnson C.A., Spurr J.O., Beck R.W. for the Optic Neuritis Study Group. Visual field profile of optic neuritis. One-year follow-up in the Optic Neuritis Treatment Trial. Arch Ophthalmology. 1994;112:946–53. DOI: 10.1001/ archopht.1994.01090190094027
9. Salter A.R., Tyry T., Vollmer T., Cutter G.R., Marrie R.A. “Seeing” in NARCOMS: a look at vision-related quality of life in the NARCOMS registry. Multiple Sclerosis Journal. 2013;9:953–60. DOI: 10.1177/1352458512469694
10. Sawa M., Gomi F., Toyoda A. A microperimeter that provides fixation pattern and retinal sensitivity measurement. Japanese Journal of Ophthalmology. 2006;50:111–5. DOI: 10.1007/s10384-005-0292-y
11. Кошелев Д.И., Сироткина И.В., Лебедев И.В. Положение области фиксации и значимые характеристики движений глаза при нарушении центрального зрения. Вестник Оренбургского государственного университета. 2009;12:74–77. [Koshelev D.I., Sirotkina I.V., Lebedev I.V. Position of the fixation region and significant characteristics of eye movements in cases of central vision disturbance. Annals of Orenburg State University=Vestnik Orenburgskogo gosudarstvennogo universiteta. 2009;12:74–77 (In Russ.)]
12. Mendoza-Santiesteban C. E, Lopez-Felipe D., Fernandez-Cherkasova L., Hernandez-Echavarria O., Hernandez-Silva Y., Gonzalez-Garcia A. Microperimetry in the Study of Neuro-ophthalmic Diseases. Seminars in Ophthalmology. 2010;25:136–43. DOI: 10.3109/08820538.2010.500201
13. Romano M.R., Angi M., Romano F. Macular sensitivity change in multiple sclerosis followed with microperimetry. European Journal of Ophthalmology. 2007;17:441–4.
14. Иойлева Е.Э., Кривошеева М.С. Микропериметрия при оптическом неврите вследствие рассеянного склероза. Офтальмохирургия. 2016;3:33–38. [Ioyleva E.E., Krivosheva M.S. Microperimetry by optical neuritis due to multiple sclerosis. Fyodorov Journal of Ophthalmic Surgery=Oftal’mokhirurgiya. 2016;3:33–38. (In Russ.)] DOI: 10.25276/0235-4160-2016-3-33-38
15. Педанова Е.К., Качалина Г.Ф., Крыль Л.А., Буряков Д.А. Ценность микропериметрии как метода оценки эффективности лечения у пациентов с очень низкими зрительными функциями. Современные технологии в офтальмологии. 2014;1:81–82. [Pedanova E.K., Kachalina G.F., Kryl L.A., Buryakov D.A. The value of microperimetry as a method of evaluating the effectiveness of treatment in patients with a very low visual functions. Modern technologies in ophthalmology=Sovremennye tekhnologii v oftal’mologii. 2014;1:81–2. (In Russ.)]
16. Иойлева Е.Э., Кривошеева М.С. Способ проведения микропериметрии при атрофии зрительного нерва. Патент RU 2631638, 22.09.2016. [Ioyleva E.E., Krivosheeva M.S. A method for performing microperimetry in optic nerve atrophy. Patent RU 2631638, 22.09.2016. (In Russ.)]
17. Никифоров А.С., Гусева М.Р. Офтальмоневрология. Москва: ГЭОТАР-Медиа; 2014:656. [Nikiforov A.S., Guseva M.R., Ophtalmoneurology. Moscow: GEOTARMedia; 2014:656. (In Russ.)]
18. Гусев Е.И. Рассеянный склероз и другие демиелинизирующие заболевания. Москва: Миклош, 2004:540. [Gusev E.I. Multiple sclerosis and other demyelinating diseases. Moscow: Miklosh, 2004:540. (In Russ.)]
19. Гусева М.Р. Рассеянный склероз и его офтальмологические проявления у детей разного возраста. Российская детская офтальмология. 2014;2:51–59. [Guseva M.R. Multiple sclerosis and its ophthalmological manifestations in children of different ages. Russian ophthalmology of children=Rossiiskaya detskaya oftal’mologiya. 2014;2:51–59. (In Russ.)]
20. Optic Neuritis Study Group. Visual function 15 years after optic neuritis: a final follow-up report from the Optic Neuritis Treatment Trial. Opththalmology. 2008B;115:1079–82. DOI: 10.1016/j.ophtha.2007.08.004
Review
For citations:
Ioyleva E.E., Krivosheeva M.S., Markova E.Yu. Modern Technologies in the Examination of Patients with Optic Nerve Atrophy Due to Multiple Sclerosis. Ophthalmology in Russia. 2018;15(2S):246-253. (In Russ.) https://doi.org/10.18008/1816-5095-2018-2S-246-253